How should an elderly patient with dementia who is engaging in coprophagia by eating her own and other residents' stool in a memory‑care unit of an assisted‑living facility be managed?

Management of Coprophagia in Dementia

This patient requires immediate environmental modifications to prevent access to fecal material, combined with a systematic investigation of underlying medical causes and consideration of haloperidol if behavioral interventions fail.

Immediate Safety and Environmental Interventions

The first priority is preventing access to fecal material through environmental controls 1:

• Implement supervised toileting with immediate cleanup to eliminate access to the patient's own stool
• Install door alarms or monitoring systems to prevent wandering into other residents' rooms 1
• Increase direct supervision during high-risk periods when the behavior typically occurs
• Ensure the environment is not over- or under-stimulating and establish predictable routines 1

These environmental modifications represent "low-hanging fruit" that must be addressed before escalating to pharmacologic interventions 1.

Systematic Medical Investigation

Before attributing this behavior solely to dementia, conduct a thorough investigation of treatable medical causes 1:

• Screen for urinary tract infection, dehydration, and constipation as these physical problems commonly trigger neuropsychiatric symptoms 1
• Review all medications for those with potential behavioral side effects and discontinue if possible 1
• Assess for untreated pain (arthritis, other sources) as pain can manifest as aberrant behaviors 1
• Evaluate for seizure disorders, cerebral lesions, or new neurologic changes that may be contributing 2
• Address sensory impairments (hearing, vision) that may be exacerbating confusion 1

Staff and Caregiver Education

A critical pitfall is that caregivers often lack understanding that dementia causes these behaviors rather than the patient "doing this on purpose" 1:

• Educate memory care staff that coprophagia in dementia is associated with medial temporal lobe atrophy and represents a neurologic symptom, not willful behavior 2
• Train staff in effective communication strategies appropriate for the patient's dementia stage 1
• Establish structured routines and meaningful activities to reduce boredom and provide engagement 1
• Ensure adequate support during eating and drinking occasions as social interaction may improve overall behavior 1

Pharmacologic Intervention

If behavioral and environmental strategies fail after appropriate trial, pharmacologic treatment should be considered:

• Haloperidol appears to be the most effective medication for treating coprophagia in dementia, with documented success in discontinuing the behavior 2
• SSRIs (such as sertraline) may be effective, particularly if depression or anxiety are present 3
• Optimize any pre-existing psychiatric medication regimen if the patient has underlying psychiatric conditions predating the dementia 1

The evidence base specifically identifies haloperidol as associated with discontinuation of coprophagic behavior in patients with neurodegenerative dementia and medial temporal lobe atrophy 2.

Critical Safety Consideration

Coprophagia carries a risk of fatal asphyxiation from aspiration of fecal boluses, as documented in case reports 4. This underscores the urgency of careful monitoring and intervention, as this behavior poses immediate mortality risk beyond infection concerns.

Collaborative Treatment Planning

Work with the interdisciplinary team including nursing, social work, and occupational therapy to brainstorm targeted strategies specific to this behavior 1. The approach should involve:

• Creating a treatment plan collaboratively with all staff members who interact with the patient 1
• Implementing both generalized strategies (enriching environment, improving caregiver skills) and targeted strategies directed at eliminating this specific behavior 1
• Monitoring response to interventions and adjusting the plan as needed

The behavior is associated with neurodegenerative dementia and likely reflects moderate-to-severe medial temporal lobe atrophy 2, making it a manifestation of advanced disease requiring comprehensive management rather than a simple behavioral problem.